In the last trading session, 1.87 million shares of the Evolent Health Inc (NYSE:EVH) were traded, and its beta was 1.56. Most recently the company’s share price was $21.78, and it changed around $0.75 or 3.57% from the last close, which brings the market valuation of the company to $2.53B. EVH currently trades at a discount to its 52-week high of $35.00, offering almost -60.7% off that amount. The share price’s 52-week low was $17.98, which indicates that the current value has risen by an impressive 17.45% since then. We note from Evolent Health Inc’s average daily trading volume that its 10-day average is 2.22 million shares, with the 3-month average coming to 2.02 million.

Evolent Health Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.20. If we narrow it down even further, the data shows that 0 out of 13 analysts rate the stock as a Sell; another 7 rate it as Overweight. Among the rest, 0 recommended EVH as a Hold, whereas 6 deemed it a Buy, and 0 rated it as Underweight. Evolent Health Inc is expected to report earnings per share of 0.26 for the current quarter.

Evolent Health Inc (NYSE:EVH) trade information

Instantly EVH has showed a green trend with a performance of 3.57% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 24.00 on recent trading dayincreased the stock’s daily price by 9.25%. The company’s shares are currently down -34.06% year-to-date, but still down -8.14% over the last five days. On the other hand, Evolent Health Inc (NYSE:EVH) is 11.24% up in the 30-day period. We can see from the shorts that 13.89 million shares have been sold at a short interest cover period of 6.29 day(s).

The consensus price target as assigned by Wall Street analysts is $44, which translates to bulls needing to increase their stock price by 50.5% from its current value. Analyst projections state that EVH is forecast to be at a low of $28 and a high of $51.

Evolent Health Inc (EVH) estimates and forecasts

Evolent Health Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -25.99 percent over the past six months and at a 51.72% annual growth rate that is well above the industry average of 21.50%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 85.70% in revenue this quarter, and will report an increase of 20.00% in the next quarter. The year-over-year growth rate is expected to be 31.20%, up from the previous year.

Consensus estimates provided by 14 financial analysts predict the company will bring in an average of 636.43M in revenue for the current quarter. 14 analysts expect Evolent Health Inc to make 644.4M in revenue for the current ending quarter. Forecasts for the next quarter put sales growth at 26.50%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -13.43%. Evolent Health Inc earnings are expected to increase by 41.54% in 2024, but the outlook is positive 30.00% per year for the next five years.

EVH Dividends

Evolent Health Inc’s next quarterly earnings report is expected to be released on 2024-Aug-08.

Evolent Health Inc (NYSE:EVH)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 3.99% of Evolent Health Inc shares, and 113.38% of them are in the hands of institutional investors. The stock currently has a share float of 118.09%. Evolent Health Inc stock is held by 354.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-03-31, it held 9.6094% of the shares, which is about 10.92 million shares worth $357.91 million.

FMR LLC, with 9.3251% or 10.59 million shares worth $347.32 million as of 2024-03-31, holds the second largest percentage of outstanding shares.